Could also mean over the 52 weeks the 50mg group improved by 0.81 points on that scale, with very low probability chance is causing this as comparing to placebo there is a big difference (such small p value).. It's not entirely clear to me from the presentation, others may know more.
Either way I like both scenarios, but improvement in the eyes of the physician (not less progression or stabilisation, but improvement!) would be a great outcome and corroborate even better with UMSARS 1 (patient reported) "less progression" findings. Cheers IMO.
- Forums
- ASX - By Stock
- ATH
- Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
ATH
alterity therapeutics limited
Add to My Watchlist
7.14%
!
1.3¢

Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy, page-257
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $119.6M |
Open | High | Low | Value | Volume |
1.4¢ | 1.5¢ | 1.3¢ | $123.8K | 8.854M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 22048002 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 980000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 22048002 | 0.013 |
29 | 15409733 | 0.012 |
21 | 12916145 | 0.011 |
35 | 16013355 | 0.010 |
19 | 7368542 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 980000 | 4 |
0.015 | 22152091 | 15 |
0.016 | 3136642 | 9 |
0.017 | 6029558 | 8 |
0.018 | 12493520 | 21 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |